Cariati Federica, D'Argenio Valeria, Izquierdo Raul, Tomaiuolo Rossella
KronosDNA Srl, Spinoff of Università Federico II, Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.
Ann Transl Med. 2020 Mar;8(6):353. doi: 10.21037/atm.2020.02.61.
Life Sciences research, enhancing the occurrence of innovation, is able to impact clinical decision-making, both at diagnosis and therapy. Indeed, starting from the knowledge of specific needs and of technical-scientific demands, researchers can conceive and experiment innovative solutions. Despite these strengths, transferring research to the market in Life Sciences shows considerable criticalities. The aim of this paper is to provide concrete evidences on the processes of technology transfer based on the exploitation of the results obtained by KronosDNAsrl, an academic spin-off focused on reproductive medicine.
Different tools were used to evaluate the technical feasibility (validation of the results obtained with the prototype) and to manage the technology transfer process of One4Two.
The different analyses we carried out showed the feasibility of the proposed solution. As a result, the One4Two prototype has been developed and validated.
Here, we provide a strength of evidences on how knowledge obtained by translational research on "bench" can be used to be transferred to the market on "benchmark" enabling innovation in Laboratory Medicine. In addition, the model described for One4Two can be easily transferred to other products.
生命科学研究能够促进创新的出现，进而影响临床诊断和治疗过程中的决策。实际上，从特定需求以及技术科学要求出发，研究人员能够构思并试验创新解决方案。尽管具备这些优势，但生命科学领域的研究成果向市场转化仍面临诸多关键问题。本文旨在基于专注于生殖医学的学术衍生公司KronosDNAsrl所获成果的利用情况，为技术转移过程提供具体证据。
运用不同工具评估技术可行性（验证原型所获结果）并管理One4Two的技术转移过程。
我们开展的不同分析表明所提解决方案具有可行性。因此，One4Two原型已研发并验证。
在此，我们提供了有力证据，证明“实验台”上的转化研究所得知识如何能够用于向“基准”市场转移，从而推动检验医学领域的创新。此外，为One4Two所描述的模型能够轻松转移至其他产品。
Zotero 插件
